Prosecution Insights
Last updated: July 17, 2026

Marshall, Gerstein & Borun LLP (Nu -30938)

15 pending office actions • 1 client • 15 examiners • 13 art units • 0 of 15 (0%) have an AI response strategy ready • 5 patents granted in the last 365 days

Quality Metrics (n=423 apps, methodology: how we score firms)

77.3%
Allowance Rate
n=423
+0.68σ
Allowance Rate (norm)
n=423
3.4
OAs to Allowance
n=126
-0.09σ
OAs to Allow (norm)
n=126
1203 days
Time to Allowance
n=126
+18.9pp
Interview Lift
n=423
34.4%
RCE Rate
n=423
0.0%
Appeal Rate
n=423

Rejection Performance (% of received rejections ultimately overcome)

§101 Overcome
n=1 (min 20)
§102 Overcome
n=15 (min 20)
72.2%
§103 Overcome
n=90
74.1%
§112 Overcome
n=27

Specialization & Scale

A61K, B82Y, C12N
Top CPC Subclasses
38%
Top-3 CPC Share
n=423
0
Practitioners
n=423
Apps / Practitioner
n=423 (min 20)

Portfolio Summary

15
Total Pending OAs
8
Non-Final OAs
7
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 12 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

3
Overdue
1
Due this week
4
Due this month
1
Due in next 60 days
3
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 12 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (3)Due ≤ 7 days (1)Due ≤ 30 days (4)Due ≤ 60 days (1)Due later (3)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
9
Medium (60%)
4
Easy (27%)
2
Unknown (13%)

Rejection Statute Mix

BucketCases
§103 only9 (60%)
§112 only3 (20%)
Double-patenting only1 (7%)
No statute on record2 (13%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

15
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

150 h
Manual time on pending OAs
30 h
Time saved (low, 20%)
52 h
Time saved (mid, 35%)
1.3 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
GUSSOW, ANNE 1 58.4% +42.2%
CHONG, KIMBERLY 1 72.4% +12.6%
BUNNER, BRIDGET E 1 64.2% +19.8%
MCCOLLUM, ANDREA K 1 60.9% +32.1%
TRAN, CHRISTINA L 1 48.1% +43.5%
FAY, ZOHREH ALEMZADEH 1 52.0% -6.4%
PETERS, ALEC JON 1 68.4% +58.0%
CASH, KAILEY ELIZABETH 1 31.3% +56.7%
CHUNDURU, SURYAPRABHA 1 53.4% +17.8%
MOAZZAMI, NAGHMEH NINA 1 72.3% +43.4%

Interview Candidates (9)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17621088 FORCED INTERCALATION (FIT)-APTAMERS: PROBES BASED ON FORCED INTERCALATION CHUNDURU, SURYAPRABHA 38d overdue
17743422 TUNABLE ANCHOR FOR LIPOSOMAL SPHERICAL NUCLEIC ACID ASSEMBLY TRAN, CHRISTINA L 23d overdue
17634908 CONTROLLING THE DNA HYBRIDIZATION CHAIN REACTION CASH, KAILEY ELIZABETH 5d
17749977 SYNERGISTIC IMMUNOSTIMULATION THROUGH THE DUAL ACTIVATION OF TLR3/9 WITH SPHERICAL NUCLEIC ACIDS MCCOLLUM, ANDREA K 12d
17752407 ENCODING HIERARCHICAL ASSEMBLY PATHWAYS OF PROTEINS WITH DNA BUNNER, BRIDGET E 28d
17635444 MATERIALS AND METHODS FOR ACTIVATING ANTIGEN-SPECIFIC T CELL RESPONSES PETERS, ALEC JON 57d
17311108 Protein Crystal Engineering Through DNA Hybridization Interactions MOAZZAMI, NAGHMEH NINA 79d
18283710 CRISPR-MEDIATED CLEAVAGE OF OLIGONUCLEOTIDE-DETECTABLE MARKER CONJUGATES FOR DETECTION OF TARGET ANALYTES GUSSOW, ANNE

Client Portfolio (1 client)

Client (Assignee)Pending OAs
Northwestern University 15

Top Art Units

Art UnitApps
16832
16372
16361
16471
16741
16171
16411
16811
16521
16191

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
18283710 CRISPR-MEDIATED CLEAVAGE OF OLIGONUCLEOTIDE-DETECTABLE MARKER CONJUGATES FOR DETECTION OF TARGET ANALYTES Northwestern University GUSSOW, ANNE 1683 §103 Non-Final OA Pending Sep 22, 2023
17814211 ADOPTIVE CELL THERAPY USING SPHERICAL NUCLEIC ACIDS (SNAS) Northwestern University CHONG, KIMBERLY 1636 §112 Non-Final OA Pending Jul 21, 2022
17752407 ENCODING HIERARCHICAL ASSEMBLY PATHWAYS OF PROTEINS WITH DNA Northwestern University BUNNER, BRIDGET E 1647 §112 Non-Final OA 28d Pending May 24, 2022
17749977 SYNERGISTIC IMMUNOSTIMULATION THROUGH THE DUAL ACTIVATION OF TLR3/9 WITH SPHERICAL NUCLEIC ACIDS Northwestern University MCCOLLUM, ANDREA K 1674 Other Final Rejection 12d Pending May 20, 2022
17743422 TUNABLE ANCHOR FOR LIPOSOMAL SPHERICAL NUCLEIC ACID ASSEMBLY Northwestern University TRAN, CHRISTINA L 1637 Other Non-Final OA 23d overdue Pending May 12, 2022
17760990 HIGH DENSITY LIPOPROTEIN-LIKE NANOPARTICLES AS INDUCERS OF FERROPTOSIS IN CANCER Northwestern University FAY, ZOHREH ALEMZADEH 1617 §103 Non-Final OA 27d Pending Mar 16, 2022
17635444 MATERIALS AND METHODS FOR ACTIVATING ANTIGEN-SPECIFIC T CELL RESPONSES Northwestern University PETERS, ALEC JON 1641 §112 Final Rejection 57d Pending Feb 15, 2022
17634908 CONTROLLING THE DNA HYBRIDIZATION CHAIN REACTION Northwestern University CASH, KAILEY ELIZABETH 1683 §103 Final Rejection 5d Pending Feb 11, 2022
17621088 FORCED INTERCALATION (FIT)-APTAMERS: PROBES BASED ON FORCED INTERCALATION Northwestern University CHUNDURU, SURYAPRABHA 1681 §103 Non-Final OA 38d overdue Pending Dec 20, 2021
17311108 Protein Crystal Engineering Through DNA Hybridization Interactions Northwestern University MOAZZAMI, NAGHMEH NINA 1652 §103 Final Rejection 79d Pending Jun 04, 2021
17054441 SELF-MANAGEABLE ABNORMAL SCAR TREATMENT WITH SPHERICAL NUCLEIC ACID (SNA) TECHNOLOGY Northwestern University NGUYEN, JOHN P 1619 §103 Non-Final OA 70d Pending Nov 10, 2020
17076607 SPHERICAL NUCLEIC ACIDS WITH DENDRITIC LIGANDS Northwestern University SHIN, DANA H 1635 DP Final Rejection Pending Oct 21, 2020
17046482 ADDRESSING NANOMEDICINE COMPLEXITY THROUGH NOVEL HIGH-THROUGHPUT SCREENING AND MACHINE LEARNING Northwestern University BEIL, RANDI LYNN 1684 §103 Final Rejection 69d Pending Oct 09, 2020
16975987 NANOPATTERNING FOR CONTROLLING CELL CYTOSKELETON Northwestern University STAVROU, CONSTANTINA E 1632 §103 Final Rejection 22d Pending Aug 26, 2020
16611548 CONJUGATION OF PEPTIDES TO SPHERICAL NUCLEIC ACIDS (SNAS) USING TRACELESS LINKERS Northwestern University VYAS, KEYUR ANILKUMAR 1637 §103 Non-Final OA 5d overdue Pending Nov 07, 2019

Managing Marshall, Gerstein & Borun LLP (Nu -30938)'s Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month